Income StatementBalance SheetCash FlowBusiness Segments
Johnson & Johnson logo

Johnson & Johnson Cash Flow Statement

Operating, investing, and financing cash movements

Johnson & Johnson generated $24.2B in operating cash flow over the trailing twelve months. After $4.6B in capital expenditures, free cash flow was $19.6B. Free cash flow increased 0.2% year-over-year. Based on the Q3 2025 filing.

Net Cash From Operating (TTM)$24.2BNet Cash From Investing (TTM)-$20.4BNet Cash From Financing (TTM)-$5.5BCapital Expenditures (TTM)$4.6BDepreciation And Amortization (TTM)$7.4BNet Change In Cash (TTM)-$1.7B
Latest FilingQ3 2025
Report Date2025-10-22
Market Cap$579.15B
P/E Ratio23.06
ROE33.62%

Investing

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Acquired in-process research and development$0.0——$14.0M$355.0M$16.0M
Acquisitions, net of cash acquired$13.0B$338.0M$1.0M$0.0$14.5B$1.0M
Capital expenditures$976.0M$1.0B$1.6B$795.0M$1.0B$1.2B
Credit Support Agreements Activity, Net$53.0M-$276.0M$267.0M-$3.0M-$268.0M$25.0M
Net cash from investing activities-$13.7B-$3.1B-$1.3B-$297.0M-$18.3B-$542.0M
Other investing activities$81.0M$16.0M$72.0M$30.0M$36.0M$33.0M
Proceeds from maturities/sales of investments$727.0M$466.0M$290.0M$218.0M$735.0M$489.0M
Proceeds from sale of property, plant and equipment$363.0M$50.0M$52.0M$279.0M$53.0M$76.0M
Purchases of investments$554.0M$280.0M$262.0M$251.0M$180.0M$246.0M

Operating

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Change in accounts payable$2.9B$2.3B—-$2.1B$1.2B$2.0B
Change in accounts receivable$884.0M$96.0M—$926.0M$1.4B-$111.0M
Change in inventories$391.0M$299.0M$90.0M$146.0M$510.0M$748.0M
Change in other assets-$532.0M$2.8B-$768.0M$1.3B$4.9B$1.5B
Change in other liabilities-$2.6B$2.7B$359.0M-$6.5B$583.0M-$270.0M
Other working capital changes-$56.0M-$75.0M$0.0$40.0M$1.0M-$49.0M
Deferred income taxes-$695.0M$90.0M-$16.0M$2.2B$825.0M$2.2B
Depreciation and amortization$1.8B$1.8B$1.9B$1.8B$1.9B$1.8B
Impairment charges$194.0M$0.0$26.0M$30.0M$0.0$93.0M
Gain (Loss) on Sale of Assets and Asset Impairment Charges$223.0M$2.0M$1.0M$75.0M-$1.0M$57.0M
Net cash from operating activities$5.6B$8.0B$7.0B$4.2B$3.9B$9.2B
Net income$4.7B$2.7B$3.4B$11.0B$5.5B$5.2B
Provision for credit losses$0.0-$11.0M$22.0M-$4.0M$7.0M-$9.0M
Stock-based compensation$341.0M$295.0M$238.0M$288.0M$410.0M$347.0M

Financing

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Proceeds from issuance of debt$6.7B$1.0M$0.0$9.1B$0.0$0.0
Repayments of debt$802.0M$1.0M$649.0M$751.0M$3.0M$1.0B
Dividends paid$3.0B$3.0B$3.0B$3.0B$3.1B$3.1B
Settlement of Acquired Convertible Debt$242.5M$242.5M$242.5M———
Net cash from financing activities$7.5B-$9.9B-$1.3B$10.4B-$5.7B-$8.9B
Proceeds from short-term borrowings$8.7B-$2.0B$3.3B$8.8B$565.0M$1.3B
Proceeds from issuance of common stock$95.0M$424.0M$124.0M$450.0M$107.0M$1.3B
Repurchases of common stock$136.0M$539.0M$282.0M$2.1B$0.0$1.9B

Other

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Effect of exchange rate changes on cash-$85.0M$119.0M-$198.0M$70.0M$154.0M-$46.0M
Net increase (decrease) in cash-$595.0M-$4.9B$4.1B$14.4B-$19.9B-$346.0M

Supplemental

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Income taxes paid$1.7B$1.7B$1.7B———
Interest paid$477.8M$477.8M$477.8M———

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.